Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Frontiers in Physiology
|
April 29, 2021
The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19
Thomas Gille, Lucile Sesé, Eric Aubourg, et al.
Medicina Clinica
|
August 2, 2001
[Effects of levofolinic acid on plasma homocysteine concentrations in healthy and young women in preconceptional care]
E Fabre, M Gallo, A C Lou, et al.
Human Gene Therapy
|
June 2, 1998
Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels
E Van Belle, L Maillard, A Rivard, et al.
Journal of Leukocyte Biology
|
March 5, 2010
STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient
Imen Najjar, Pierre-Antoine Deglesne, Pierre Olivier Schischmanoff, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2020
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
A Simonaggio, R Elaidi, L Fournier, et al.
The Journal of Clinical Investigation
|
March 10, 2001
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation
J E Fabre, M Nguyen, K Athirakul, et al.
Free Radical Biology & Medicine
|
August 11, 2011
Catalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame?
M Hebert-Schuster, C H Cottart, C Laguillier-Morizot, et al.
Revue De Pneumologie Clinique
|
February 25, 2014
[Lung cancer, how to deal with critical situations?]
F Scotté, P Leroy, S Hans, et al.
Cancer Treatment and Research Communications
|
April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
S Ponce Aix, S Novello, E B Garon, et al.
Oncoimmunology
|
May 15, 2023
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
A Daban, C Gonnin, L Phan, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Frontiers in Physiology
|
April 29, 2021
The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19
Thomas Gille, Lucile Sesé, Eric Aubourg, et al.
Medicina Clinica
|
August 2, 2001
[Effects of levofolinic acid on plasma homocysteine concentrations in healthy and young women in preconceptional care]
E Fabre, M Gallo, A C Lou, et al.
Human Gene Therapy
|
June 2, 1998
Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels
E Van Belle, L Maillard, A Rivard, et al.
Journal of Leukocyte Biology
|
March 5, 2010
STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient
Imen Najjar, Pierre-Antoine Deglesne, Pierre Olivier Schischmanoff, et al.
Cancer Immunology, Immunotherapy : CII
|
June 21, 2020
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
A Simonaggio, R Elaidi, L Fournier, et al.
The Journal of Clinical Investigation
|
March 10, 2001
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation
J E Fabre, M Nguyen, K Athirakul, et al.
Free Radical Biology & Medicine
|
August 11, 2011
Catalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame?
M Hebert-Schuster, C H Cottart, C Laguillier-Morizot, et al.
Revue De Pneumologie Clinique
|
February 25, 2014
[Lung cancer, how to deal with critical situations?]
F Scotté, P Leroy, S Hans, et al.
Cancer Treatment and Research Communications
|
April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
S Ponce Aix, S Novello, E B Garon, et al.
Oncoimmunology
|
May 15, 2023
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
A Daban, C Gonnin, L Phan, et al.
Page
of 10